Sign in
THE NOVEL USE OF ABATACEPT AND RUXOLITINIB AS SALVAGE THERAPY IN STEROIDREFRACTORY IMMUNE-RELATED MYOCARDITIS, MYASTHENIA, AND MYOSITIS SYNDROME
Abstract   Peer reviewed

THE NOVEL USE OF ABATACEPT AND RUXOLITINIB AS SALVAGE THERAPY IN STEROIDREFRACTORY IMMUNE-RELATED MYOCARDITIS, MYASTHENIA, AND MYOSITIS SYNDROME

Stefano H. Byer, Colten C. Stewart, Udhayvir Grewal and Shareef Mansour
Journal of the American College of Cardiology, Vol.83(13 Supplement), pp.3199-3199
04/02/2024
DOI: 10.1016/S0735-1097(24)05189-1

View Online

Details

Metrics

2 Record Views